Literature DB >> 25092163

Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.

David F Schneider1, Dawn Elfenbein, Ricardo V Lloyd, Herbert Chen, Rebecca S Sippel.   

Abstract

INTRODUCTION: Follicular variant of papillary thyroid cancer (FVPTC) is the most common and fastest growing subtype of papillary thyroid cancer (PTC) with features of both PTC and follicular thyroid cancer (FTC). The purpose of this study was to determine the patient and tumor features associated with lymph node metastases (LNM) in FVPTC.
METHODS: This was a retrospective review of adult (≥18) patients with histologically confirmed diagnoses of FVPTC within the SEER database between 1988 and 2009. LNM were defined by at least two lymph nodes with metastatic disease. To determine factors associated with LNM, we constructed a multivariate logistic regression model from significant variables (p < 0.05) identified on univariate analysis. Similarly, we used a Cox proportional hazards model to understand the relative importance of LNM in determining disease-specific mortality (DSM).
RESULTS: Of the 20,357 cases of FVPTC with lymph node data available, 1,761 (8.7%) had LNM; 61.1% of these LNM were located in the central neck and 38.9% were in the lateral neck. Extrathyroidal extension (odds ratio [OR] 2.6, 95% confidence interval [CI] 2.2-3.0, p < 0.01) and multifocality (OR 3.0, 95% CI 2.5-3.6, p < 0.01) were the strongest predictors of LNM. Importantly, LNM did not independently predict DSM (p = 0.52). Tumor size >4 cm (hazards ratio [HR] 5.3, 95% CI 2.2-12.8, p < 0.01) and extrathyroidal extension (HR 8.2, 95% CI 3.0-22.0, p < 0.01) were the strongest predictors of DSM.
CONCLUSIONS: LNM occur in less than 10% of patients with FVPTC but do not impact DSM. Instead, DSM in FVPTC is related to size and local invasion.

Entities:  

Mesh:

Year:  2014        PMID: 25092163      PMCID: PMC4275358          DOI: 10.1245/s10434-014-3964-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  36 in total

1.  Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma.

Authors:  Francis T Hall; Jeremy L Freeman; Sylvia L Asa; David G Jackson; Nigel J Beasley
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

2.  Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.

Authors:  Sachin Gupta; Oluyomi Ajise; Linda Dultz; Beverly Wang; Daisuke Nonaka; Jennifer Ogilvie; Keith S Heller; Kepal N Patel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-03

Review 3.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

4.  A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up.

Authors:  Raymon H Grogan; Sharone P Kaplan; Hongyuan Cao; Roy E Weiss; Leslie J Degroot; Cassie A Simon; Omran M A Embia; Peter Angelos; Edwin L Kaplan; Rebecca B Schechter
Journal:  Surgery       Date:  2013-09-26       Impact factor: 3.982

Review 5.  Papillary thyroid carcinoma: an update.

Authors:  Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

6.  Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.

Authors:  Xiao-Min Yu; Yin Wan; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

7.  Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.

Authors:  Radina Ivanova; Paula Soares; Patrícia Castro; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2001-12-12       Impact factor: 4.064

8.  Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.

Authors:  Nobuyuki Wada; Quan-Yang Duh; Kiminori Sugino; Hiroyuki Iwasaki; Kaori Kameyama; Takashi Mimura; Koichi Ito; Hiroshi Takami; Yoshinori Takanashi
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

9.  Lymph node ratio predicts recurrence in papillary thyroid cancer.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-01-23

10.  Impact of lymph node ratio on survival in papillary thyroid cancer.

Authors:  David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

View more
  6 in total

1.  Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.

Authors:  Marco Raffaelli; Carmela De Crea; Luca Sessa; Guido Fadda; Celestino Pio Lombardi; Rocco Bellantone
Journal:  Endocrine       Date:  2018-05-16       Impact factor: 3.633

2.  The prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.

Authors:  Lin-Yun He; Wei-Wei Wang; Balde Alpha Ibrahima; Shuai Han; Zhou Li; Zhai Cai; Miao-Liang Chen; Bao-Zhu Chen; Hui-Shi Tan; Hai-Shan Zeng; Xiao-Li Dai; Min-Wei Zhou; Gang-Qing Zhang; Guo-Xin Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?

Authors:  Wei Long; Di Hu; Ling Zhou; Yueye Huang; Wen Zeng; Sichao Chen; Yihui Huang; Man Li; Min Wang; Wei Zhou; Jianglong Huang; Wei Wei; Chao Zhang; Zeming Liu; Liang Guo
Journal:  Front Oncol       Date:  2020-12-11       Impact factor: 6.244

4.  The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.

Authors:  Krzysztof Kaliszewski; Dorota Diakowska; Łukasz Nowak; Beata Wojtczak; Jerzy Rudnicki
Journal:  BMC Cancer       Date:  2020-11-30       Impact factor: 4.430

5.  The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER.

Authors:  Jianing Tang; Deguang Kong; Qiuxia Cui; Kun Wang; Dan Zhang; Xing Liao; Yan Gong; Gaosong Wu
Journal:  Onco Targets Ther       Date:  2018-06-19       Impact factor: 4.147

6.  Surgical management for follicular variant of papillary thyroid carcinoma.

Authors:  Jianing Tang; Deguang Kong; Lupin Bu; Gaosong Wu
Journal:  Oncotarget       Date:  2017-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.